|
|
Volumn 164, Issue 2, 2002, Pages 381-382
|
|
Treatment of children with familial hypercholesterolemia with colestilan, a newly developed bile acid-binding resin [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN B;
CHOLESTEROL;
COLESTILAN;
COLESTYRAMINE;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN RECEPTOR;
TRIACYLGLYCEROL;
ADOLESCENT;
BLOOD SAMPLING;
CHILD;
CHILDHOOD;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DIET RESTRICTION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERANCE;
FAMILIAL DISEASE;
FAMILIAL HYPERCHOLESTEROLEMIA;
FEMALE;
HETEROZYGOSITY;
HOMOZYGOSITY;
HUMAN;
LETTER;
LIPID BLOOD LEVEL;
MALE;
PERIPHERAL LYMPHOCYTE;
PRIORITY JOURNAL;
RECEPTOR BINDING;
STATISTICAL SIGNIFICANCE;
TRIACYLGLYCEROL BLOOD LEVEL;
XANTHOMA;
ADMINISTRATION, ORAL;
ADOLESCENT;
ANION EXCHANGE RESINS;
CHILD;
CHILD, PRESCHOOL;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
COLESTIPOL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYPERLIPOPROTEINEMIA TYPE II;
MALE;
PROBABILITY;
PROSPECTIVE STUDIES;
SAMPLING STUDIES;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
TRIGLYCERIDES;
|
|
EID: 0036802386
PISSN: 00219150
EISSN: None
Source Type: Journal
DOI: 10.1016/S0021-9150(02)00047-3 Document Type: Letter |
|
Times cited : (5)
|
|
References (6)
|
